<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
   <channel>
      <title>Bones/Orthopaedics News</title>
      <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/</link>
      <description>Bones/Orthopaedics News</description>
      <language>en-en</language>
      <webMaster>padayatra@bk.ru</webMaster>
      <copyright>http://poznaisebya.com/newseng</copyright>
      <pubDate>Fri, 21 Nov 2008 07:02:41 GMT.</pubDate>
      <lastBuildDate>Sat, 21 Jun 2008 04:40:02 GMT</lastBuildDate>
      <image>
         <title>Bones/Orthopaedics News</title>
         <url>http://poznaisebya.com/newseng/i/logo.png</url>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/</link>
      </image>

      <item>
         <title>Depuy Spine Launches Next Generation Eagle And Swift Anterior Cervical Plating Systems</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-21-04-40-02-502.html</link>
         <description>DePuy Spine,  Inc. introduced its next generation in anterior Cervical fixation: the EAGLE&amp;trade;  Plus Rigid and the SWIFT&amp;trade;   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-21-04-40-02-502.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sat, 21 Jun 2008 04:40:02 GMT</pubDate>
      </item>

      <item>
         <title>Correcting Spinal Deformities - DSM Dyneema And University Hospital Maastricht Collaborate To Explore New Solutions</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-20-00-40-03-166.html</link>
         <description>DSM Dyneema and the university hospital Maastricht (azM),  The Netherlands,  announced a joint agreement to conduct research into new solutions that can improve surgical outcomes for patients with spinal deformities.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-20-00-40-03-166.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Fri, 20 Jun 2008 00:40:03 GMT</pubDate>
      </item>

      <item>
         <title>Mechanism Uncovered That Contribues To The Appropriate Formation Of The Spine</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-20-00-40-02-674.html</link>
         <description>The Stowers Institute&#039;s Pourquie Lab has shed light on the mechanism causing animals to develop the appropriate number of vertebrae.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-20-00-40-02-674.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Fri, 20 Jun 2008 00:40:02 GMT</pubDate>
      </item>

      <item>
         <title>By Using Growth Hormone Scientists From Granada Drastically Reduce The Wait Time For New Teeth Implant</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-18-21-20-05-291.html</link>
         <description>The use of the growth hormone in oral implantology has managed to regenerate the bone and hasten the integration between the bone base and the dental implant.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-18-21-20-05-291.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Wed, 18 Jun 2008 21:20:05 GMT</pubDate>
      </item>

      <item>
         <title>Topical NSAID As Effective As Tablets For Knee Pain</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-18-21-20-04-892.html</link>
         <description>Research published by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has found that non-steroidal anti-inflammatory (NSAIDs) creams is as effective as tablets for the treatment of chronic knee pain in older people.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-18-21-20-04-892.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Wed, 18 Jun 2008 21:20:04 GMT</pubDate>
      </item>

      <item>
         <title>Neurocrine Biosciences Completes &#039;Petal Study&#039; Treatment Phase For Endometriosis</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-18-21-20-03-229.html</link>
         <description>Neurocrine Biosciences,  Inc. (Nasdaq: NBIX) announced that the elagolix 0603 Phase IIb trial (Petal Study) has completed the 6-month treatment phase.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-18-21-20-03-229.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Wed, 18 Jun 2008 21:20:03 GMT</pubDate>
      </item>

      <item>
         <title>Canadians Without Risk Factors Need Bone Density Measurements Only Once Every 5 Years According To Largest Ever Canadian Study On Osteoporosis</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-17-17-40-05-959.html</link>
         <description>Dr David Goltzman and his team from the Research Institute of the McGill University Health Centre (RI MUHC) and McGill University - along with colleagues from across Canada - have issued new recommendations to public health authorities about how to best cope with osteoporosis,  a bone disease which leads to increased risk of fracture,  particularly in the elderly.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-17-17-40-05-959.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Tue, 17 Jun 2008 17:40:05 GMT</pubDate>
      </item>

      <item>
         <title>Adult Stem Cells Improve Fracture Healing</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-17-17-40-04-759.html</link>
         <description>Adult stem cells improve healing of broken bones and could eventually serve as a new treatment for the 10 to 20 percent of fractures that fail to heal,  according to a new study.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-17-17-40-04-759.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Tue, 17 Jun 2008 17:40:04 GMT</pubDate>
      </item>

      <item>
         <title>Boehringer Ingelheim Announces First Positive Health Technology Assessments For Novel Oral Anticoagulant Pradaxa reg; dabigatran Etexilate </title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-15-11-00-03-699.html</link>
         <description>The Scottish Medicines Consortium (SMC) has accepted Pradaxa (dabigatran etexilate) for routine use within the National Health Service (NHS) of Scotland for its currently licensed indication: the prevention of venous thromboembolic events in adults who have undergone total hip or knee replacement surgery.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-15-11-00-03-699.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sun, 15 Jun 2008 11:00:03 GMT</pubDate>
      </item>

      <item>
         <title>Genta Announces Initial Clinical Trial Results For G4544, A Novel Potent Drug For Bone Disease</title>
         <link>http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-14-12-10-22-776.html</link>
         <description>Genta Incorporated (OTC Bulletin Board: GNTA) announced the release of final results from the Company&#039;s Phase 1 clinical trial of G4544,  a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/bones-orthopaedics-news/news_2008-06-14-12-10-22-776.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sat, 14 Jun 2008 12:10:22 GMT</pubDate>
      </item>

   </channel>
</rss>
